Show simple item record

dc.contributor.authorRueda, Fabián
dc.contributor.authorCéspedes, María Virtudes
dc.contributor.authorSánchez-Chardi, Alejandro
dc.contributor.authorSeras-Franzoso, Joaquin
dc.contributor.authorPesarrodona, Mireia
dc.contributor.authorFerrer-Miralles, Neus
dc.contributor.authorVázquez, Esther
dc.contributor.authorRinas, Ursula
dc.contributor.authorUnzueta, Ugutz
dc.contributor.authorMamat, Uwe
dc.contributor.authorMangues, Ramón
dc.contributor.authorGarcía-Fruitós, Elena
dc.contributor.authorVillaverde, Antonio
dc.date.accessioned2016-06-21T14:12:13Zen
dc.date.available2016-06-21T14:12:13Zen
dc.date.issued2016en
dc.identifier.citationStructural and functional features of self-assembling protein nanoparticles produced in endotoxin-free Escherichia coli. 2016, 15 (1):59 Microb. Cell Fact.en
dc.identifier.issn1475-2859en
dc.identifier.pmid27059706en
dc.identifier.doi10.1186/s12934-016-0457-zen
dc.identifier.urihttp://hdl.handle.net/10033/613872en
dc.description.abstractProduction of recombinant drugs in process-friendly endotoxin-free bacterial factories targets to a lessened complexity of the purification process combined with minimized biological hazards during product application. The development of nanostructured recombinant materials in innovative nanomedical activities expands such a need beyond plain functional polypeptides to complex protein assemblies. While Escherichia coli has been recently modified for the production of endotoxin-free proteins, no data has been so far recorded regarding how the system performs in the fabrication of smart nanostructured materials.
dc.language.isoenen
dc.titleStructural and functional features of self-assembling protein nanoparticles produced in endotoxin-free Escherichia coli.en
dc.typeArticleen
dc.contributor.departmentHelmholtz Centre for infection research, Inhoffenstr. 7, 38124 Braunschweig, Germany.en
dc.identifier.journalMicrobial cell factoriesen
refterms.dateFOA2018-06-12T17:21:59Z
html.description.abstractProduction of recombinant drugs in process-friendly endotoxin-free bacterial factories targets to a lessened complexity of the purification process combined with minimized biological hazards during product application. The development of nanostructured recombinant materials in innovative nanomedical activities expands such a need beyond plain functional polypeptides to complex protein assemblies. While Escherichia coli has been recently modified for the production of endotoxin-free proteins, no data has been so far recorded regarding how the system performs in the fabrication of smart nanostructured materials.


Files in this item

Thumbnail
Name:
Rueda et al.pdf
Size:
3.171Mb
Format:
PDF
Description:
Open Access publication

This item appears in the following Collection(s)

Show simple item record